2021 Opportunities For Healthtech Investment: A Legal Firm’s View
For life sciences investors, the past year has been the busiest period in recent memory, say Goodwin partners Sophie McGrath and David Mardle. But what are the industry's drivers and key investor trends in 2021?
You may also be interested in...
With the UK on the cusp of a public consultation on the UKCA marking, directors at the ABHI stress the vital need for the MHRA to review all options in setting the right medtech regulatory framework.
Reaching deep and being resourceful were the in-demand attributes that medtech industry leaders brought to bear when the COVID-19 pandemic stretched health care providers almost to breaking point.
Singapore drives much of the medtech regulatory and policy thought leadership in the ASEAN region, as shown in its regulatory collaboration with Thailand and actions on cybersecurity and packaging waste.